PT  - JOURNAL ARTICLE
AU  - Klümper, Niklas
AU  - Ralser, Damian J
AU  - Zarbl, Romina
AU  - Schlack, Katrin
AU  - Schrader, Andres Jan
AU  - Rehlinghaus, Marc
AU  - Hoffmann, Michèle J
AU  - Niegisch, Günter
AU  - Uhlig, Annemarie
AU  - Trojan, Lutz
AU  - Steinestel, Julie
AU  - Steinestel, Konrad
AU  - Wirtz, Ralph M
AU  - Sikic, Danijel
AU  - Eckstein, Markus
AU  - Kristiansen, Glen
AU  - Toma, Marieta
AU  - Hölzel, Michael
AU  - Ritter, Manuel
AU  - Strieth, Sebastian
AU  - Ellinger, Jörg
AU  - Dietrich, Dimo
TI  - <em>CTLA4</em> promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma
AID  - 10.1136/jitc-2021-002949
DP  - 2021 Aug 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e002949
VI  - 9
IP  - 8
4099  - http://jitc.bmj.com/content/9/8/e002949.short
4100  - http://jitc.bmj.com/content/9/8/e002949.full
SO  - J Immunother Cancer2021 Aug 01; 9
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.